The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Immune Response Causes Joint Pain In Chikungunya Patients
A study has found that patients with chikungunya fever experience persistent joint pain due to high amounts of pro-inflammatory cytokines being produced.
China Will Train 2,000 Experts In Nuclear Fusion
China has pledged to train 2,000 skilled experts to carry out research on nuclear fusion.
Six-Foot Long Fruit-Eating Lizard From The Philippines Makes Top 10 New Species List
The top 10 new species in 2011 includes a six-foot long fruit-eating monitor lizard, found in the Northern Sierra Madre Forest on Luzon Island in the Philippines.
Swine Flu Viruses In Hong Kong Are Increasing In Diversity
An epidemiological study of the swine flu virus in Hong Kong has found increasing viral diversity in live pigs over the past three decades.
Maori Found To Have High Resistance To Standard Heart Drug
Maori people are more likely to have resistance to the standard heart drug streptokinase, says a new study.
Gene Discovery For Rare New Muscle Wasting Disease
Researchers at The University of Western Australia have discovered a gene mutation in a rare new form of muscle wasting disease.
Link Between Vitamin D Deficiency And Pneumonia Deaths
Researchers in New Zealand have found that severe vitamin D deficiency is associated with a higher mortality among pneumonia patients, but no causal relationship has been proven.
Sanofi And DNDi To Tackle Nine Neglected Tropical Diseases
Sanofi and the Drugs for Neglected Diseases initiative will develop new treatments for nine neglected tropical diseases listed by the World Health Organization.
Davos Life Sciences Takes Tocotrienol Product Into Phase I Trials
Davos Life Science announced today preliminary results of a Phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer.